dc.contributor.author |
Rupenthal, Ilva |
en |
dc.contributor.author |
Thakur, Sachin |
en |
dc.coverage.spatial |
Auckland, New Zealand |
en |
dc.date.accessioned |
2018-10-05T00:41:21Z |
en |
dc.date.issued |
2017-11-23 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/39015 |
en |
dc.description.abstract |
While the eye is readily accessible from the outside of the body, it is a rather isolated organ with a number of barriers and elimination mechanisms in place to protect it from the environment, rendering efficient treatment difficult. To enhance drug bioavailability in the eye, a number of delivery approaches have been investigated over recent decades, increasing drug retention and permeation while also allowing for sustained drug release over prolonged periods. This presentation will give an overview of the various models used to test novel ocular delivery approaches. |
en |
dc.relation.ispartof |
New Zealand-Australian Controlled Release Society 2017 Joint Workshop |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
Ex-vivo Drug Diffusion and Penetration Models for Ocular Drug Delivery |
en |
dc.type |
Presentation |
en |
dc.rights.holder |
Copyright: The author |
en |
pubs.finish-date |
2017-11-23 |
en |
pubs.start-date |
2017-11-22 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Oral Presentation (Not presented at a conference) |
en |
pubs.subtype |
Invited |
en |
pubs.elements-id |
725639 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Pharmacy |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Ophthalmology Department |
en |
pubs.record-created-at-source-date |
2018-02-20 |
en |